[Parenteral treatment of severe bronchopulmonary infections using trimethoprim and sulfamethoxazole].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000409:Alanine / Q000008:administration & dosage*; D000890:Anti-Infective Agents / Q000008:administration & dosage*; D001987:Bronchiectasis / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy; D005260:Female; D005493:Folic Acid Antagonists / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011001:Pleuropneumonia / Q000188:drug therapy; D011018:Pneumonia, Pneumococcal / Q000188:drug therapy; D011743:Pyrimidines / Q000008:administration & dosage*; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000382:microbiology; D013419:Sulfamethizole / Q000008:administration & dosage; D013432:Sulfathiazoles / Q000008:administration & dosage*; D014295:Trimethoprim / Q000008:administration & dosage
D000890:Anti-Infective Agents; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D013432:Sulfathiazoles; D013419:Sulfamethizole; D014295:Trimethoprim; D000409:Alanine
Zur parenteralen Behandlung schwerer bronchopulmonaler Infekte mit Trimethoprime+Sulfamethoxazol.